Oncology Supportive Care Education - Minimizing the Risk of Cervical Cancer

Instructions to Receive Credit

Saturday, June 15, 2024, 8:00 AM - Tuesday, June 15, 2027, 5:00 PM

This series provides oncology-related education to healthcare professionals caring for oncology patients and loved ones. This session is a recording of the live session that focus's on the use of screening and prevention in minimizing the risk of cervical cancer as well as diagnostic tools and treatment modalities used to manage cervical cancer.

1. Understand the role of screening in preventing and detecting cervix cancer.
2. Understand some of the treatment modalities for managing invasive cancer.
3. Understand the role of vaccination in preventing HPV infection and lowering risk of cervix cancer.
4. Recognize ways to collaborate as an interdisciplinary team while providing care to the oncology patient.

Bibliography

Disclaimer:
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner.

ADA Statement:
ADA accommodations will be made in accordance with the law.  If you require ADA accommodations, please indicate what your needs are at the time of registration.  We cannot ensure the availability of appropriate accommodations without prior notification.

In support of improving patient care, Avera is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designations:

	This activity was planned by and for the healthcare team, and learners will receive 1.0 IPCE credits for learning and change.
	Medicine CME:  Avera designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
	Nurse CE: Avera designates this activity for a maximum of 1.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
	Social Work: As a Jointly Accredited Organization, Avera is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 Clinical Competency continuing education credit(s).
	Pharmacy CE: Avera designates this activity for 1.00 ACPE contact hour(s). Pharmacists and pharmacy technicians should claim only the credit commensurate with the extent of their participation in the activity. Credit will be uploaded to the NABP CPE Monitor® within 30 days after the activity completion. Per ACPE rules, Avera does not have access nor the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information (NABP ID and DOB (MMDD)) to receive credit.

Mitigation of Relevant Financial Relationships

Avera adheres to the Joint Accreditation’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.